Cole, Peter D.
Kim, Soo Young
Li, Yuelin
Schembri, Adrian
Kelly, Kara M.
Sulis, Maria-Luisa
Vrooman, Lynda
Welch, Jennifer J. G.
Ramjan, Sameera
Silverman, Lewis B.
Sands, Stephen A.
Funding for this research was provided by:
National Cancer Institute (NIH/NCI R21-CA187226, NIH/NCI R21-CA187226)
Article History
Received: 10 June 2022
Accepted: 27 December 2022
First Online: 10 January 2023
Declarations
:
: The authors declare no competing interests.
: The institutional review boards of each of the treating institutions (Dana-Farber Cancer Institute, Boston, MA; Montefiore Medical Center, Bronx, NY; Columbia University Medical Center, New York, NY; and Hasbro Children's Hospital, Providence, RI) approved both clinical protocols. Informed consent was provided by the subjects’ guardians or by those patients over the age of 18 years. Written assent was provided if age-appropriate, following institutional guidelines.
: The authors declare no competing interest, with the exception of Adrian Schembri who was an employee and stockholder of Cogstate at the time this study was conducted.